LIFECORE BIOMEDICAL, INC. Repayments of Long-Term Debt
LIFECORE BIOMEDICAL, INC. (LFCR) reported Repayments of Long-Term Debt of $0 for the 12-month period ending 2024-05-26, per its 10-K filed 2024-08-26.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2024-08-26
- LIFECORE BIOMEDICAL, INC. repayments of long-term debt for the quarter ending 2024-05-26 was -$386.00K, a 100.32% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. repayments of long-term debt for the quarter ending 2024-02-25 was $193.00K, a 93.82% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. repayments of long-term debt for the quarter ending 2023-11-26 was $193.00K, a 293.88% increase year-over-year.
- LIFECORE BIOMEDICAL, INC. repayments of long-term debt for the quarter ending 2023-08-27 was $0.00, a 100.00% decline year-over-year.
- LIFECORE BIOMEDICAL, INC. repayments of long-term debt for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- LIFECORE BIOMEDICAL, INC. repayments of long-term debt for fiscal 2023 was $123.69M, a 43.14% increase from fiscal 2022.
- LIFECORE BIOMEDICAL, INC. repayments of long-term debt for fiscal 2022 was $86.41M, a 24.29% decline from fiscal 2021.
- LIFECORE BIOMEDICAL, INC. repayments of long-term debt for fiscal 2021 was $114.13M, a 925.89% increase from fiscal 2020.
| Period end | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 12 month |
|---|---|---|---|---|
| 2024-05-26 | -$386.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-26 | -$193.00K derived: sum of 2 quarters · filed 2024-08-26 | $0.00 derived: sum of 3 quarters · filed 2024-08-26 | $0.00 10-K · filed 2024-08-26 |
| 2024-02-25 | $193.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-09 | $386.00K derived: sum of 2 quarters · filed 2024-08-09 | $386.00K 10-Q · filed 2024-08-09 | $120.88M derived: sum of 4 quarters · filed 2024-08-26 |
| 2023-11-26 | $193.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $193.00K 10-Q · filed 2024-08-09 | $120.68M derived: sum of 3 quarters · filed 2024-08-26 | $123.81M derived: sum of 4 quarters · filed 2024-08-26 |
| 2023-08-27 | $0.00 10-Q · filed 2024-08-09 | $120.49M derived: sum of 2 quarters · filed 2024-08-26 | $123.61M derived: sum of 3 quarters · filed 2024-08-26 | $123.66M derived: sum of 4 quarters · filed 2024-08-26 |
| 2023-05-28 | $120.49M derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-26 | $123.61M derived: sum of 2 quarters · filed 2024-08-26 | $123.66M derived: sum of 3 quarters · filed 2024-08-26 | $123.69M 10-K · filed 2024-08-26 |
| 2023-02-26 | $3.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-08-09 | $3.17M derived: sum of 2 quarters · filed 2024-08-09 | $3.20M 10-Q · filed 2024-08-09 | $3.23M derived: sum of 4 quarters · filed 2024-08-26 |
| 2022-11-27 | $49.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $76.00K 10-Q · filed 2024-08-09 | $111.00K derived: sum of 3 quarters · filed 2024-08-26 | $45.06M derived: sum of 4 quarters · filed 2024-08-26 |
| 2022-08-28 | $27.00K 10-Q · filed 2024-08-09 | $62.00K derived: sum of 2 quarters · filed 2024-08-26 | $45.01M derived: sum of 3 quarters · filed 2024-08-26 | $45.05M derived: sum of 4 quarters · filed 2024-08-26 |
| 2022-05-29 | $35.00K derived: 10-K 12 month − 10-K 9 month · filed 2024-08-26 | $44.98M derived: sum of 2 quarters · filed 2024-08-26 | $45.02M derived: sum of 3 quarters · filed 2024-08-26 | $86.41M 10-K · filed 2024-08-26 |
| 2022-02-27 | $44.95M derived: 10-K 9 month − 10-K 6 month · filed 2024-03-20 | $44.99M derived: sum of 2 quarters · filed 2024-03-20 | $86.38M 10-K · filed 2024-03-20 | $86.41M derived: sum of 4 quarters · filed 2024-03-20 |
| 2021-11-28 | $38.00K derived: 10-K 6 month − 10-K 3 month · filed 2024-03-20 | $41.43M 10-K · filed 2024-03-20 | $41.46M derived: sum of 3 quarters · filed 2024-03-20 | $135.49M derived: sum of 4 quarters · filed 2024-03-20 |
| 2021-08-29 | $41.39M 10-K · filed 2024-03-20 | $41.42M derived: sum of 2 quarters · filed 2024-03-20 | $135.46M derived: sum of 3 quarters · filed 2024-03-20 | $147.49M derived: sum of 4 quarters · filed 2024-03-20 |
| 2021-05-30 | $35.00K derived: 10-K 12 month − 10-K 9 month · filed 2024-03-20 | $94.07M derived: sum of 2 quarters · filed 2024-03-20 | $106.10M derived: sum of 3 quarters · filed 2024-03-20 | $114.13M 10-K · filed 2024-03-20 |
| 2021-02-28 | $94.03M derived: 10-K 9 month − 10-Q 6 month · filed 2024-03-20 | $106.06M derived: sum of 2 quarters · filed 2024-03-20 | $114.09M 10-K · filed 2024-03-20 | $117.13M derived: sum of 4 quarters · filed 2024-03-20 |
| 2020-11-29 | $12.03M derived: 10-Q 6 month − 10-K 3 month · filed 2022-01-07 | $20.06M 10-Q · filed 2022-01-07 | $23.09M derived: sum of 3 quarters · filed 2024-03-20 | $26.13M derived: sum of 4 quarters · filed 2024-03-20 |
| 2020-08-30 | $8.03M 10-K · filed 2024-03-20 | $11.06M derived: sum of 2 quarters · filed 2024-03-20 | $14.09M derived: sum of 3 quarters · filed 2024-03-20 | $16.63M derived: sum of 4 quarters · filed 2024-03-20 |
| 2020-05-31 | $3.03M derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-03-16 | $6.06M derived: sum of 2 quarters · filed 2023-03-16 | $8.60M derived: sum of 3 quarters · filed 2023-03-16 | $11.13M 10-K/A · filed 2023-03-16 |
| 2020-02-23 | $3.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-04-08 | $5.56M derived: sum of 2 quarters · filed 2021-04-08 | $8.09M 10-Q · filed 2021-04-08 | $10.62M derived: sum of 4 quarters · filed 2021-07-29 |
| 2019-11-24 | $2.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-01-07 | $5.06M 10-Q · filed 2021-01-07 | $7.59M derived: sum of 3 quarters · filed 2021-07-29 | $7.61M derived: sum of 4 quarters · filed 2021-07-29 |
| 2019-08-25 | $2.53M 10-Q · filed 2020-10-07 | $5.06M derived: sum of 2 quarters · filed 2021-07-29 | $5.08M derived: sum of 3 quarters · filed 2021-07-29 | $6.35M derived: sum of 4 quarters · filed 2021-07-29 |
| 2019-05-26 | $2.53M derived: 10-K 12 month − 10-Q 9 month · filed 2021-07-29 | $2.55M derived: sum of 2 quarters · filed 2021-07-29 | $3.82M derived: sum of 3 quarters · filed 2021-07-29 | $5.09M 10-K · filed 2021-07-29 |
| 2019-02-24 | $21.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-04-03 | $1.29M derived: sum of 2 quarters · filed 2020-04-03 | $2.56M 10-Q · filed 2020-04-03 | $3.83M derived: sum of 4 quarters · filed 2020-08-14 |
| 2018-11-25 | $1.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-01-02 | $2.54M 10-Q · filed 2020-01-02 | $3.81M derived: sum of 3 quarters · filed 2020-08-14 | $5.08M derived: sum of 4 quarters · filed 2020-08-14 |
| 2018-08-26 | $1.27M 10-Q · filed 2019-10-03 | $2.54M derived: sum of 2 quarters · filed 2020-08-14 | $3.80M derived: sum of 3 quarters · filed 2020-08-14 | $5.08M derived: sum of 4 quarters · filed 2020-08-14 |
| 2018-05-27 | $1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2020-08-14 | $2.53M derived: sum of 2 quarters · filed 2020-08-14 | $3.81M derived: sum of 3 quarters · filed 2020-08-14 | $5.08M 10-K · filed 2020-08-14 |
| 2018-02-25 | $1.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-04-04 | $2.53M derived: sum of 2 quarters · filed 2019-04-04 | $3.81M 10-Q · filed 2019-04-04 | $5.08M derived: sum of 4 quarters · filed 2019-08-01 |
| 2017-11-26 | $1.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-01-07 | $2.54M 10-Q · filed 2019-01-07 | $3.81M derived: sum of 3 quarters · filed 2019-08-01 | $5.08M derived: sum of 4 quarters · filed 2019-08-01 |
| 2017-08-27 | $1.27M 10-Q · filed 2018-10-05 | $2.54M derived: sum of 2 quarters · filed 2019-08-01 | $3.81M derived: sum of 3 quarters · filed 2019-08-01 | $56.60M derived: sum of 4 quarters · filed 2019-08-01 |
| 2017-05-28 | $1.27M derived: 10-K 12 month − 10-Q 9 month · filed 2019-08-01 | $2.54M derived: sum of 2 quarters · filed 2019-08-01 | $55.33M derived: sum of 3 quarters · filed 2019-08-01 | $57.24M 10-K · filed 2019-08-01 |
| 2017-02-26 | $1.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-04-05 | $54.06M derived: sum of 2 quarters · filed 2018-04-05 | $55.97M 10-Q · filed 2018-04-05 | $58.47M derived: sum of 4 quarters · filed 2018-08-09 |
| 2016-11-27 | $52.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-01-05 | $54.70M 10-Q · filed 2018-01-05 | $57.20M derived: sum of 3 quarters · filed 2018-08-09 | $65.07M derived: sum of 4 quarters · filed 2018-08-09 |
| 2016-08-28 | $1.91M 10-Q · filed 2017-09-28 | $4.41M derived: sum of 2 quarters · filed 2018-08-09 | $12.28M derived: sum of 3 quarters · filed 2018-08-09 | $14.64M derived: sum of 4 quarters · filed 2018-08-09 |
| 2016-05-29 | $2.50M derived: 10-K 12 month − 10-Q 9 month · filed 2018-08-09 | $10.37M derived: sum of 2 quarters · filed 2018-08-09 | $12.74M derived: sum of 3 quarters · filed 2018-08-09 | $14.65M 10-K · filed 2018-08-09 |
| 2016-02-28 | $7.87M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-04-07 | $10.23M derived: sum of 2 quarters · filed 2017-04-07 | $12.15M 10-Q · filed 2017-04-07 | $13.94M derived: sum of 4 quarters · filed 2018-03-15 |
| 2015-11-29 | $2.36M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-01-05 | $4.28M 10-Q · filed 2017-01-05 | $6.07M derived: sum of 3 quarters · filed 2018-03-15 | $7.80M derived: sum of 4 quarters · filed 2018-03-15 |
| 2015-08-30 | $1.92M 10-Q · filed 2016-09-29 | $3.71M derived: sum of 2 quarters · filed 2018-03-15 | $5.44M derived: sum of 3 quarters · filed 2018-03-15 | $7.37M derived: sum of 4 quarters · filed 2018-03-15 |
| 2015-05-31 | $1.79M derived: 10-K/A 12 month − 10-Q 9 month · filed 2018-03-15 | $3.53M derived: sum of 2 quarters · filed 2018-03-15 | $5.46M derived: sum of 3 quarters · filed 2018-03-15 | $6.87M 10-K/A · filed 2018-03-15 |
| 2015-03-01 | $1.73M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-03-30 | $3.66M derived: sum of 2 quarters · filed 2016-03-30 | $5.07M 10-Q · filed 2016-03-30 | $6.48M derived: sum of 4 quarters · filed 2016-08-01 |
| 2014-11-30 | $1.93M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-01-07 | $3.34M 10-Q · filed 2016-01-07 | $4.75M derived: sum of 3 quarters · filed 2016-08-01 | $6.15M derived: sum of 4 quarters · filed 2016-08-01 |
| 2014-08-31 | $1.41M 10-Q · filed 2015-10-01 | $2.82M derived: sum of 2 quarters · filed 2016-08-01 | $4.22M derived: sum of 3 quarters · filed 2016-08-01 | $5.96M derived: sum of 4 quarters · filed 2016-08-01 |
| 2014-05-25 | $1.41M derived: 10-K 12 month − 10-Q 9 month · filed 2016-08-01 | $2.81M derived: sum of 2 quarters · filed 2016-08-01 | $4.55M derived: sum of 3 quarters · filed 2016-08-01 | $5.93M 10-K · filed 2016-08-01 |
| 2014-02-23 | $1.40M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-04-02 | $3.14M derived: sum of 2 quarters · filed 2015-04-02 | $4.53M 10-Q · filed 2015-04-02 | $7.06M derived: sum of 4 quarters · filed 2015-07-31 |
| 2013-11-24 | $1.75M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-01-09 | $3.13M 10-Q · filed 2015-01-09 | $5.66M derived: sum of 3 quarters · filed 2015-07-31 | $7.05M derived: sum of 4 quarters · filed 2015-07-31 |
| 2013-08-25 | $1.38M 10-Q · filed 2014-10-08 | $3.92M derived: sum of 2 quarters · filed 2015-07-31 | $5.30M derived: sum of 3 quarters · filed 2015-07-31 | $7.03M derived: sum of 4 quarters · filed 2015-07-31 |
| 2013-05-26 | $2.54M derived: 10-K 12 month − 10-Q 9 month · filed 2015-07-31 | $3.92M derived: sum of 2 quarters · filed 2015-07-31 | $5.64M derived: sum of 3 quarters · filed 2015-07-31 | $7.01M 10-K · filed 2015-07-31 |
| 2013-02-24 | $1.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-28 | $3.11M derived: sum of 2 quarters · filed 2014-03-28 | $4.48M 10-Q · filed 2014-03-28 | $5.47M derived: sum of 4 quarters · filed 2014-08-01 |
| 2012-11-25 | $1.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-01-03 | $3.09M 10-Q · filed 2014-01-03 | $4.09M derived: sum of 3 quarters · filed 2014-08-01 | $5.09M derived: sum of 4 quarters · filed 2014-08-01 |
| 2012-08-26 | $1.37M 10-Q · filed 2013-09-26 | $2.37M derived: sum of 2 quarters · filed 2014-08-01 | $3.37M derived: sum of 3 quarters · filed 2014-08-01 | $4.70M derived: sum of 4 quarters · filed 2014-08-01 |
| 2012-05-27 | $999.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-08-01 | $2.00M derived: sum of 2 quarters · filed 2014-08-01 | $3.33M derived: sum of 3 quarters · filed 2014-08-01 | $4.33M 10-K · filed 2014-08-01 |
| 2012-02-26 | $1.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-04-04 | $2.33M derived: sum of 2 quarters · filed 2013-04-04 | $3.33M 10-Q · filed 2013-04-04 | $4.33M derived: sum of 4 quarters · filed 2013-08-07 |
| 2011-11-27 | $1.33M derived: 10-Q 6 month − 10-Q/A 3 month · filed 2013-01-04 | $2.33M 10-Q · filed 2013-01-04 | $3.33M derived: sum of 3 quarters · filed 2013-08-07 | |
| 2011-08-28 | $1.00M 10-Q/A · filed 2013-01-02 | $2.00M derived: sum of 2 quarters · filed 2013-08-07 | ||
| 2011-05-29 | $1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-08-07 | $3.94M 10-K · filed 2013-08-07 | ||
| 2011-02-27 | $2.94M 10-Q · filed 2012-03-28 | |||
| 2010-11-28 | $1.94M 10-Q · filed 2012-01-05 | |||
| 2010-08-29 | $615.00K 10-Q · filed 2011-10-05 | |||
| 2010-05-30 | $387.00K 10-K · filed 2012-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 | |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Annexon, Inc. (ANNX) | United States | $0.147B | -4.22 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |